Hepatitis Monthly

Published by: Kowsar

Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft Reinfection

Alessio Aghemo 1 , * , Sherrie Bhoori 2 , Stella De Nicola 2 , Vincenzo Mazzaferro 2 and Massimo Colombo 2
Authors Information
1 Angela Maria e Antonio Migliavacca Center for Liver Disease, First Division of Gastroenterology, Fondazione IRCCS Ca Granda ospedale Maggiore Policlinico, University of Milan, alessio.aghemo@policlinico.mi.it, Italy
2 Hepato-oncology Group, Department of Gastroenterology and Surgery, IRCCS national Cancer Institute, Italy
Article information

To Cite: Aghemo A, Bhoori S, Nicola S, Mazzaferro V, Colombo M. et al. Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft Reinfection, Hepat Mon. Online ahead of Print ; 12(6):411-414. doi: 10.5812/hepatmon.6135.

Abstract
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments